Potential Cure for Sickle Cell Clears Hurdle for Approval

(MedPage Today) -- An FDA advisory committee meeting on Tuesday did nothing to dispel expectations that the investigational agent exagamglogene autotemcel (exa-cel) will become the first approved gene therapy for sickle cell disease (SCD). Members...
Source: MedPage Today Public Health - Category: American Health Source Type: news